Results 21 to 30 of about 87,940 (259)

BEHÇET’S DISEASE [PDF]

Acta Medica Iranica, 2005
Behçet’s disease (BD) which is classified among vasculitides is a systemic disease with various manifestations. Its clinical course is characterized by attacks and remissions.
F. Davatchi, F. Shahram, C. Chams, H. Chams A. Nadji   +3 more
doaj   +1 more source

Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature

Biomedicines, 2023
Refractory cutaneous manifestations constitute a significant unmet need in patients with cutaneous lupus (CLE), even in the setting of systemic lupus erythematosus (SLE) with otherwise good control of inflammatory manifestations.
Giovanni Paolino, Giuseppe A. Ramirez, Chiara Calabrese, Luca Moroni, Vittoria Giulia Bianchi, Enrica P. Bozzolo, Santo Raffaele Mercuri, Lorenzo Dagna   +7 more
doaj   +1 more source

Cutaneous Manifestations of Diabetic Patients: A Cross-sectional Clinical Descriptive Study

Journal of Dermatology and Dermatologic Surgery
Background: Diabetes mellitus is a prevalent global endocrine disorder, with cutaneous manifestations being among its most common complications. Purpose: The purpose of this study was to determine the frequency and clinical characteristics of cutaneous ...
Muhsin A. Al-Dhalimi, Ammar N. Yaseen
doaj   +1 more source

Cutaneous manifestations of COVID‐19 among healthcare workers: A Case report and literature review

Clinical Case Reports, 2022
Common clinical features of COVID‐19 are increasingly known but cutaneous manifestations are rarely described among healthcare workers. A review of cutaneous manifestations of COVID‐19 especially among healthcare workers (HCW) is thus required.
Youssfi Imen, Najla Mechergui, Noureddine Litaiem, Imen Youssef, Soumaya Gara, Faten Zeglaoui, Soumaya Rammeh, Nizar Ladhari   +7 more
doaj   +1 more source

Clinical presentation and evaluation of dermatomyositis

Indian Journal of Dermatology, 2012
Dermatomyositis (DM) is a chronic inflammatory disorder of the skin and muscles. Evidence supports that DM is an immune-mediated disease and 50-70% of patients have circulating myositis-specific auto-antibodies.
Umaima Marvi, Lorinda Chung, David F Fiorentino   +2 more
doaj   +1 more source

Cutaneous manifestations of coronavirus disease 2019 in 458 confirmed cases: A systematic review

Journal of Family Medicine and Primary Care, 2020
Background: The coronavirus disease 2019 (COVID-19) pandemic has affected the whole world for a short span of time. As it is a novel virus, its manifestations have been slowly revealed.
Rashmi Jindal, Payal Chauhan
doaj   +1 more source

Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin, Tianyuan Yang, Minglei Liu, Haiyang Luo, Jing Yuan, Ke Zhang, Xinsheng Han, Jing Yang, Yuming Xu   +8 more
wiley   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source

Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.

PLoS ONE, 2013
Cutaneous manifestations of Lyme borreliosis in Europe include erythema migrans (EM) and acrodermatitis chronica atrophicans (ACA); the most common non-cutaneous manifestations are Lyme neuroborreliosis (LNB) and Lyme arthritis. The purpose of this study
Franc Strle, Gary P Wormser, Paul Mead, Kanthi Dhaduvai, Michael V Longo, Omosalewa Adenikinju, Sandeep Soman, Yodit Tefera, Vera Maraspin, Stanka Lotrič-Furlan, Katarina Ogrinc, Jože Cimperman, Eva Ružić-Sabljić, Daša Stupica   +13 more
doaj   +1 more source

Mucocutaneous Disease Activity and Damage Accrual in Systemic Lupus Erythematosus: Analyses From the Asia‐Pacific Lupus Collaboration Longitudinal Cohort Study

Arthritis Care &Research, EarlyView.
Objective This research article aims to describe the prevalence, associations, and health‐related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analyzed (2013–2021).
Amanda M. Saracino, Yanjie Hao, Dylan Hansen, Yi‐Hsing Chen, Alberta Hoi, Vera Golder, Jiacai Cho, Aisha Lateef, Worawit Louthrenoo, Laniyati Hamijoyo, Shue Fen Luo, Yeong‐Jian Jan Wu, Sandra Navarra, Leonid Zamora, Chak Sing Lau, Shirley Chan, Zhanguo Li, Hai‐hong Yao, Sargunan Sockalingam, B. M. D. B. Basnayake, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Jun Kikuchi, Yuko Kaneko, Tsutomu Takeuchi, Madelynn Chan, Sang‐Cheol Bae, Fiona Goldblatt, Sean O'Neill, Geraldine Hassett, Kristine Ng, Nicola Tugnet, Mark Sapsford, Yih Jia Poh, Michael Tee, Cherica Tee, Naoaki Ohkubo, Yoshiya Tanaka, Rangi Kandane‐Rathnayake, Eric Morand, Shereen Oon, Mandana Nikpour   +42 more
wiley   +1 more source